• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于炎症性肠病的体外模型和离体系统。

In vitro models and ex vivo systems used in inflammatory bowel disease.

作者信息

Joshi Abhishek, Soni Arun, Acharya Sanjeev

机构信息

Department of Pharmacology, SSR College of Pharmacy, Union Territory of Dadra 396230 Sayli, Silvassa, India.

Department of Pharmacognosy, SSR College of Pharmacy, Union Territory of Dadra 396230 Sayli, Silvassa, India.

出版信息

In Vitro Model. 2022;1(3):213-227. doi: 10.1007/s44164-022-00017-w. Epub 2022 Apr 25.

DOI:10.1007/s44164-022-00017-w
PMID:37519330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9036838/
Abstract

Inflammatory bowel disease (IBD) is a chronic, relapsing gastrointestinal condition. Ulcerative colitis and Crohn's disease are types of inflammatory bowel disease. Over many decades, the disease has been a topic of study, with experts still trying to figure out its cause and pathology. Researchers have established many in vivo animal models, in vitro cell lines, and ex vivo systems to understand its cause ultimately and adequately identify a therapy. However, in vivo animal models cannot be regarded as good models for studying IBD since they cannot completely simulate the disease. Furthermore, because species differences are a crucial subject of concern, in vitro cell lines and ex vivo systems can be employed to recreate the condition properly. In vitro models serve as the starting point for biological and medical research. Ex vivo and in vitro models for replicating gut physiology have been developed. This review aims to present a clear understanding of several in vitro and ex vivo models of IBD and provide insights into their benefits and limits and their value in understanding intestinal physiology.

摘要

炎症性肠病(IBD)是一种慢性复发性胃肠道疾病。溃疡性结肠炎和克罗恩病是炎症性肠病的类型。几十年来,该疾病一直是研究的课题,专家们仍在试图弄清楚其病因和病理。研究人员建立了许多体内动物模型、体外细胞系和离体系统,以最终了解其病因并充分确定治疗方法。然而,体内动物模型不能被视为研究IBD的良好模型,因为它们不能完全模拟该疾病。此外,由于物种差异是一个关键的关注问题,可以采用体外细胞系和离体系统来恰当地重现病情。体外模型是生物学和医学研究的起点。已经开发出用于复制肠道生理的离体和体外模型。本综述旨在清晰地阐述几种IBD的体外和离体模型,并深入探讨它们的优点和局限性以及它们在理解肠道生理方面的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/a52ebe3c9b52/44164_2022_17_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/f9d0f1d86eb1/44164_2022_17_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/3af23ab1cbc6/44164_2022_17_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/a52ebe3c9b52/44164_2022_17_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/f9d0f1d86eb1/44164_2022_17_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/3af23ab1cbc6/44164_2022_17_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e192/11756497/a52ebe3c9b52/44164_2022_17_Fig3_HTML.jpg

相似文献

1
In vitro models and ex vivo systems used in inflammatory bowel disease.用于炎症性肠病的体外模型和离体系统。
In Vitro Model. 2022;1(3):213-227. doi: 10.1007/s44164-022-00017-w. Epub 2022 Apr 25.
2
The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip.肠道上皮模型从细胞系到芯片上肠道的发展。
Int J Mol Sci. 2021 Dec 15;22(24):13472. doi: 10.3390/ijms222413472.
3
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响:直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.
4
A Gut-Ex-Vivo System to Study Gut Inflammation Associated to Inflammatory Bowel Disease (IBD).一种用于研究与炎症性肠病(IBD)相关的肠道炎症的肠道体外系统。
Biology (Basel). 2021 Jun 30;10(7):605. doi: 10.3390/biology10070605.
5
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
6
Organoid-based regenerative medicine for inflammatory bowel disease.基于类器官的炎症性肠病再生医学
Regen Ther. 2020 Jan 13;13:1-6. doi: 10.1016/j.reth.2019.11.004. eCollection 2020 Mar.
7
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.通过RAND方法评估炎症性肠病中免疫抑制药物的适用性:意大利炎症性肠病研究小组(IG-IBD)立场声明
Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013.
8
Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.基于类器官的模型研究宿主-微生物相互作用在炎症性肠病中的作用。
J Crohns Colitis. 2021 Jul 5;15(7):1222-1235. doi: 10.1093/ecco-jcc/jjaa257.
9
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.AGA 临床实践更新:炎症性肠病患者的饮食和营养治疗:专家综述。
Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23.
10
Trends in 3D models of inflammatory bowel disease.炎症性肠病的 3D 模型的发展趋势。
Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167042. doi: 10.1016/j.bbadis.2024.167042. Epub 2024 Jan 29.

引用本文的文献

1
Gastrointestinal tract, its pathophysiology and models: A "quick" reference guide to translational studies.胃肠道、其病理生理学及模型:转化研究的“快速”参考指南。
World J Gastroenterol. 2025 Jul 28;31(28):108297. doi: 10.3748/wjg.v31.i28.108297.
2
Development of the Gut Microbial Immune and Epithelial Cellular System (GutMICS) to Investigate the Immunological Role of Gut Anaerobes.开发肠道微生物免疫与上皮细胞系统(GutMICS)以研究肠道厌氧菌的免疫作用。
Biotechnol Bioeng. 2025 Sep;122(9):2546-2558. doi: 10.1002/bit.29031. Epub 2025 May 24.
3
Improvement of the inflammation-damaged intestinal barrier and modulation of the gut microbiota in ulcerative colitis after FMT in the SHIME® model.

本文引用的文献

1
Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia.在结直肠肿瘤患者外观正常的结肠黏膜中,纳米摩尔 EP4 受体效力和与类花生酸相关的酶的表达。
BMC Gastroenterol. 2022 May 12;22(1):234. doi: 10.1186/s12876-022-02311-z.
2
Prediction of Oral Drug Absorption in Rats from In Vitro Data.基于体外数据预测大鼠口服药物的吸收情况。
Pharm Res. 2023 Feb;40(2):359-373. doi: 10.1007/s11095-022-03173-6. Epub 2022 Feb 15.
3
Transport and Interactions of Co-incubated Bi-functional Flavonoids through Inhibiting the Function of P-Glycoprotein (P-gp) Using KB/Multidrug-Resistant (MDR) Cells and Rat Everted Gut Sacs.
在SHIME®模型中,粪菌移植后溃疡性结肠炎炎症损伤肠屏障的改善及肠道微生物群的调节
BMC Complement Med Ther. 2025 Apr 21;25(1):145. doi: 10.1186/s12906-025-04889-9.
4
Thrombin-preconditioned mesenchymal stromal cell-derived extracellular vesicles attenuate experimental necrotizing enterocolitis.凝血酶预处理的间充质基质细胞衍生的细胞外囊泡可减轻实验性坏死性小肠结肠炎。
Stem Cell Res Ther. 2025 Feb 28;16(1):101. doi: 10.1186/s13287-025-04243-3.
5
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
6
Human Organ Chips Reveal New Inflammatory Bowel Disease Drivers.人体器官芯片揭示炎症性肠病新驱动因素
Res Sq. 2025 Jan 29:rs.3.rs-5627712. doi: 10.21203/rs.3.rs-5627712/v1.
7
Nanoencapsulation enhanced the performance of β-carotene for ameliorating inflammation in patient-derived organoids.纳米包封增强了β-胡萝卜素在改善患者来源类器官炎症方面的性能。
Nanomedicine (Lond). 2025 Apr;20(7):663-675. doi: 10.1080/17435889.2025.2465247. Epub 2025 Feb 13.
8
Inflammatory Bowel Disease Drivers Revealed in Human Organ Chips.人体器官芯片揭示炎症性肠病的驱动因素
medRxiv. 2024 Dec 8:2024.12.05.24318563. doi: 10.1101/2024.12.05.24318563.
9
Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.利用多酚的抗炎特性治疗炎症性肠病。
Int J Biol Sci. 2024 Oct 14;20(14):5608-5672. doi: 10.7150/ijbs.98107. eCollection 2024.
10
A Comparative Study on the Effects of Mesenchymal Stem Cells and Their Conditioned Medium on Caco-2 Cells as an In Vitro Model for Inflammatory Bowel Disease.间充质干细胞及其条件培养基对作为炎症性肠病体外模型的Caco-2细胞影响的比较研究
Int J Cell Biol. 2024 Oct 21;2024:1022338. doi: 10.1155/2024/1022338. eCollection 2024.
共孵育双功能类黄酮通过抑制 P-糖蛋白(P-gp)功能在 KB/多药耐药(MDR)细胞和大鼠外翻肠囊模型中的转运和相互作用。
J Agric Food Chem. 2022 Feb 16;70(6):1923-1933. doi: 10.1021/acs.jafc.1c07694. Epub 2022 Feb 3.
4
Regulatory Mechanism of MicroRNA-9 / Long Non-Coding RNA XIST Expression on Mouse Macrophage RAW264.7 Apoptosis Induced by Oxidized Low Density Lipoprotein.miR-9/长链非编码 RNA XIST 对氧化型低密度脂蛋白诱导的小鼠巨噬细胞 RAW264.7 细胞凋亡的调控机制。
Bioengineered. 2022 Feb;13(2):3537-3550. doi: 10.1080/21655979.2021.2018978.
5
The anti-inflammatory and protective role of interleukin-38 in inflammatory bowel disease.白细胞介素-38在炎症性肠病中的抗炎和保护作用。
J Clin Biochem Nutr. 2022 Jan;70(1):64-71. doi: 10.3164/jcbn.21-104. Epub 2021 Nov 5.
6
SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models.SEDDS 促进肉桂醛穿过黏液屏障:黏液和 Caco-2/HT29 共培养模型的观点。
Int J Pharm. 2022 Feb 25;614:121461. doi: 10.1016/j.ijpharm.2022.121461. Epub 2022 Jan 10.
7
The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip.肠道上皮模型从细胞系到芯片上肠道的发展。
Int J Mol Sci. 2021 Dec 15;22(24):13472. doi: 10.3390/ijms222413472.
8
Fabrication of chitosan-coated epigallocatechin-3-gallate (EGCG)-hordein nanoparticles and their transcellular permeability in Caco-2/HT29 cocultures.壳聚糖包裹表没食子儿茶素没食子酸酯(EGCG)-大麦醇溶蛋白纳米粒的制备及其在 Caco-2/HT29 共培养模型中的跨细胞渗透性。
Int J Biol Macromol. 2022 Jan 31;196:144-150. doi: 10.1016/j.ijbiomac.2021.12.024. Epub 2021 Dec 14.
9
Epac-2 ameliorates spontaneous colitis in Il-10 mice by protecting the intestinal barrier and suppressing NF-κB/MAPK signalling.Epac-2 通过保护肠道屏障和抑制 NF-κB/MAPK 信号通路改善 Il-10 小鼠自发性结肠炎。
J Cell Mol Med. 2022 Jan;26(1):216-227. doi: 10.1111/jcmm.17077. Epub 2021 Dec 3.
10
Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D?探索可用于预测肠道通透性和代谢的基于细胞的体外模型:我们是否准备好迎接 3D 时代?
AAPS J. 2021 Nov 22;24(1):2. doi: 10.1208/s12248-021-00665-y.